Jean-Luc Tétard

Stragen Chemical SA researches, develops and sells bulk API's and neutral ingredients. The company was founded in 1990 and is headquartered in Geneva, Switzerland.

Stragen Pharma SA is a Swiss pharmaceutical company that has been committed to the development of advanced generics since 1990. The company is based in Plan-les-Ouates, Switzerland, and has subsidiaries in Germany. The company focuses on innovation for health solutions and consistently operates under the latest quality standards to deliver Swiss tailor-made solutions for public health. Stragen offers a range of consumer health products with unique, natural formulas made from scientifically selected active ingredients. The company was founded in 1990, and the CEO is Jean-Luc Tétard.

ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA.

ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia.